No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Brentuximab Vedotin
-
Female
-
Humans
-
Immunoconjugates / therapeutic use*
-
Immunologic Factors / therapeutic use*
-
Immunosuppression Therapy / adverse effects
-
Kidney Transplantation
-
Lymphoma, Large-Cell, Anaplastic / drug therapy*
-
Lymphoma, Large-Cell, Anaplastic / etiology
-
Lymphoma, Large-Cell, Anaplastic / pathology*
-
Male
-
Middle Aged
-
Remission Induction
-
Transplant Recipients*
-
Young Adult
Substances
-
Immunoconjugates
-
Immunologic Factors
-
Brentuximab Vedotin